| 000 | 01244 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516232306.0 | ||
| 264 | 0 | _c20150407 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1744-7658 | ||
| 024 | 7 |
_a10.1517/13543784.2014.951434 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartÃnez, Pablo | |
| 245 | 0 | 0 |
_aGanitumab for the treatment of small-cell lung cancer. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cOct 2014 |
||
| 300 |
_a1423-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xmetabolism |
| 650 | 0 | 4 |
_aSmall Cell Lung Carcinoma _xdrug therapy |
| 700 | 1 | _aSales Fidalgo, Paula Alexandra | |
| 700 | 1 | _aFelip, Enriqueta | |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 23 _gno. 10 _gp. 1423-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.2014.951434 _zAvailable from publisher's website |
| 999 |
_c24160336 _d24160336 |
||